Tag: Aviragen Therapeutics
February 8, 2018
Aviragen and Vaxart Amend Terms of Merger Agreement
Aviragen Therapeutics (NASDAQ:AVIR) and Vaxart announced that the companies have agreed to amend the terms of their previously announced merger... April 4, 2017